Abattis Bioceuticals Corp. (ATTBF)

[bensondog]

Abattis (ATTBF): A Leader in Canada's Cannabis Testing Industry -- CFN Media
MKTW

Abattis (ATTBF): A Leader in Canada's Cannabis Testing Industry -- CFN Media
SEATTLE, WA--(Marketwired - Oct 18, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Canada's new cannabis testing regulations and why Abattis Bioceuticals' (OTCQB: ATTBF) Northern Vine Labs is well positioned in this burgeoning market.
In July 2016 the Globe and Mail conducted an investigation into contamination in cannabis after purchasing products from nine storefronts in Toronto. Their research team found that one-third of the samples would not pass a Health Canada safety test. Three of the nine samples contained excessively high levels of bacteria and one not only contained mold but yeast at concentrations that could cause serious lung conditions.
Surprisingly, the Controlled Drugs and Substances Act prevented government-approved cannabis testing facilities from possessing any amount of the drug brought in by the public. With hundreds of illegal dispensaries operating outside of the MMPR program, this meant that consumers had no way of knowing if their product was safe. Consequently, in August 2016, Health Canada introduced an exemption to the Controlled Drugs and Substances Act that allowed government-approved labs to test any cannabis products.
Abattis Bioceuticals' Northern Vine Labs recently secured a Controlled Substance License with Health Canada for the possession of cannabis and related active ingredients, as well as the production of extracts for the purpose of analysis. The company offers cutting-edge cannabis testing and research services to licensed producers, law enforcement and other CSLs.
Northern Vine's long-term goal is to become a partner in both cannabis testing and product development. By building up its expertise in extracts, the company is positioned to take advantage of the industry's transition from dried cannabis to more conventional delivery methods like functional foods and capsules. While the independent nature of the lab results will reassure medical professionals and patients, licensed producers would benefit from the cost-savings of outsourcing these activities.